Address: Inno Biologics Sdn Bhd Lot 1 Persiaran Negeri BBN Putra Nilai 71800 Nilai Negeri Sembilan Malaysia
Tel: +606 799 6661
Web: http://www.innobiologics.com/
INNO BIOLOGICS specialises in mammalian cell culture technology and operates the state-of-the-art cGMP facility for the production of biopharmaceuticals. The facility is built to comply with European Medical Agency (EMEA) and United States Food and Drug Administration (FDA) regulatory requirements.
We aspire to be a world leading business organisation providing biopharmaceutical development and services for better quality of life.
We offer complete services from upstream to downstream operation for the development of your therapeutic proteins. Our reliable, rapid and cost effective services will reduce risks, cost and time investment. This will ensure our customers will get the product candidates into the market in line with their vision and strategy.
With a streamlined scale-up work and transient process transfer to manufacturing scale, we are the best platform to link your discovery to market.
“Clinical trials are an area where we want to build capabilities, both internally and externally” says Novartis Malaysia’s president and managing director. Novartis, with 22 ongoing trials, is one of…
“Clinical trials are an area where we want to build capabilities, both internally and externally” says Novartis Malaysia’s president and managing director. Novartis, with 22 ongoing trials, is one of…
“Clinical trials are an area where we want to build capabilities, both internally and externally” says Novartis Malaysia’s president and managing director. Novartis, with 22 ongoing trials, is one of…
Klinsel’s CEO discusses the company’s ambitions of growth in a very competitive CRO market and stresses that local experience is truly a distinguishing factor and this is why they are…
Novo Nordisk Malaysia’s general manager shares the ongoing fight to cure diabetes and talks about the necessity to raise awareness, with for instance their current MoU with the ministry of…
Malaysia Healthcare Travel Council’s CEO is proud of her country’s healthcare system and their efforts at attracting medical tourists from all over the world, with the support of the healthcare…
Mundipharma Malaysia’s country manager discusses his company’s aim to become a reference in Malaysia for pain management, on the back of the tremendous 48 percent growth of the business last year. …
Lundbeck’s country manager gives a thorough overview of CNS disorders in Malaysia and states: “It is important to remind everyone that mental health conditions or brain diseases are not to…
MMA’s president shares the reasons why Malaysia is ranked today third in terms of healthcare quality, with a very efficient public system, high quality doctors and strong government support. However,…
IMS in Malaysia is possibly the first company to have signed a Memorandum of Understanding with the government for data provision. IMS Health’s general manager introduces this landmark and also…
Aspen Malaysia’s country manager details the company’s success in the country with a specific business model based on acquiring and remarketing originators. Although Aspen is a renowned generic player, market dynamics…
MGCC’s Executive Director discusses the opportunities and challenges for German pharma and healthcare companies to invest in Malaysia, at a time where most have decided to invest and base their…
See our Cookie Privacy Policy Here
